Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 23

Results For "platform"

1920 News Found

Abbott launches minimally invasive TriClip therapy in India
Medical Device | May 11, 2026

Abbott launches minimally invasive TriClip therapy in India

Offers a non-surgical treatment option for tricuspid regurgitation, a commonly underdiagnosed heart valve disorder linked to heart failure


CPHIA 2026 to advance Africa’s health security and resilience
Public Health | May 11, 2026

CPHIA 2026 to advance Africa’s health security and resilience

The public health summit in Addis Ababa will bring together policymakers, scientists, healthcare leaders, and global partners


Co-Diagnostics JV leases manufacturing facility in Saudi Arabia
Medical Device | May 11, 2026

Co-Diagnostics JV leases manufacturing facility in Saudi Arabia

CoMira Diagnostics will manufacture PCR diagnostic instruments and medical consumables in Sudair Industrial City


Lonza surges on biologics boom
News | May 09, 2026

Lonza surges on biologics boom

Expands manufacturing push & locks in major growth deals


Microsure secures CE mark for MUSA-3 system, appoints Alex Joseph as CEO
Medical Device | May 08, 2026

Microsure secures CE mark for MUSA-3 system, appoints Alex Joseph as CEO

The company plans to collaborate with European medical centres to expand adoption of its robotic microsurgery platform


Dr. Reddy’s and Nestle Health Science launch Celevida GLP for optimized nutritional support
Healthcare | May 08, 2026

Dr. Reddy’s and Nestle Health Science launch Celevida GLP for optimized nutritional support

Clinical guidelines and expert consensus recommend 1.2–1.5 g/kg/day protein intake during therapy to help preserve muscle mass


Thyrocare Q4 PAT surges 128% to Rs. 48.7 crore
Healthcare | May 08, 2026

Thyrocare Q4 PAT surges 128% to Rs. 48.7 crore

Diagnostic major processes 59 million tests in Q4FY26 as revenue rises 20% and specialty testing portfolio expands


Roche moves to acquire PathAI for up to $1.05 billion in major AI pathology push
News | May 08, 2026

Roche moves to acquire PathAI for up to $1.05 billion in major AI pathology push

The acquisition positions Roche more aggressively in digital pathology and precision diagnostics capabilities


Moderna’s mRNA flu vaccine outperforms standard shot in Phase 3 trial
Clinical Trials | May 08, 2026

Moderna’s mRNA flu vaccine outperforms standard shot in Phase 3 trial

NEJM study shows strong protection across strains


MilliporeSigma lands exclusive 5-year deal to test Genetix Biotherapeutics gene therapies
Biotech | May 08, 2026

MilliporeSigma lands exclusive 5-year deal to test Genetix Biotherapeutics gene therapies

The deal positions MilliporeSigma at the center of commercial manufacturing for three breakthrough gene therapies targeting sickle cell disease, ?-thalassemia, and cerebral adrenoleukodystrophy